Skip to main content
. Author manuscript; available in PMC: 2016 Nov 10.
Published in final edited form as: Bone. 2012 Nov 19;52(2):640–643. doi: 10.1016/j.bone.2012.11.012

Table 2.

Current laboratory values of patient I-1 and affected son (II-2).

Test (reference ranges) Patient Son


9/2010 4/2011
Fasting
7/2011
Fasting
4/2011
Fasting
7/2011
Fasting
Ca (8.5–10.5 mg/dL) 10.1 10.0 10.5 9.8 9.5
Phosphorus (2.6–4.5 mg/dL) 1.9 3.5 2.9 2.9 3.2
Magnesium (1.4–2.0 meq/L) 1.7 1.7 1.7 1.7 1.8
Vitamin D (> 32 ng/mL) 34 22 39 21
1,25 Vitamin D (18–78 pg/mL) 10 14 43.5 39
Albumin (3.3–5.0 g/dL) 4.3 4.2 4.4 4.8
Alkaline phosphatase (30–100 U/L) 108 78 79 103
Parathyroid hormone
  (10–60 pg/mL)
30 30 21 42 47
FGF23 (< 180 RU/mL) 785 414 70
Creatinine (0.60–1.50 mg/dL) 1.14 1.0 0.99 0.8 0.82
Glucose (70–110 mg/dL) 143
Tubular reabsorption of phosphorus
  (> 80%, calculated based on
  creatinine)
47.4% 89.7% 84.2%. 89.0% 89.8%
T1-TSH (0.40–5.00 uU/mL) 3.66 5.03 2.30
Hemoglobin (12.0–16.0 g/dL) 12.7 13.0 13.9
Fe (30–160 µg/dL) 118 80
TIBC (230–404 µg/dL) 365 303
Ferritin (10–200 ng/mL) 29 71